Registration
Registration

Agenda

Soon

12:30 PM - 1:30 PM

Registration

1:30 PM - 2:45 PM

Opening Ceremony

2:45 PM - 3:30 PM

Keynote

Precision Public Health in Cancer Screening: AI, Social Media, and Targeted Early Detection in the MENA Region

Hadi Rasheed 🇶🇦

3:30 PM - 4:00 PM

3:30 PM - 4:00 PM
Prayer & Coffee Break (Exhibition)

SESSION I

Advanced in Oncoplastic Surgery / Minimally Invasive Breast Surgery

4:00 PM - 4:20 PM

Endoscopic breast surgery – niche or future?

Fayyaz Mazari 🇸🇦

4:20 PM - 4:40 PM

Robotic Breast Surgery – from conception to reality.

Ahmed Matlakah 🇦🇪

4:40 PM - 5:00 PM

Synthetic meshes and biological matrices in breast surgery – current use and future prospects.

Saleh Al Hababeh 🇯🇴

5:00 PM - 5:20 PM

Fat grafting – from adjunct to advanced reconstructive option.

Fayyaz Mazari 🇸🇦

5:20 PM - 5:40 PM

Immediate breast reconstruction – past, present and future.

Fabio Santanelli Di Pompeo 🇮🇹

5:40 PM - 6:00 PM

5:40 PM - 6:00 PM
Panel Discussion

6:00 PM - 6:30 PM

6:00 PM - 6:30 PM
Prayer & Coffee Break (Exhibition)

SESSION II

Hands-on Session & Guideline Updates

6:30 PM - 6:50 PM

Margin guidelines for breast cancer – Is the debate over

Roaa Attieh 🇸🇦

6:50 PM - 7:10 PM

Axillary staging updates for breast cancer – Is this the end of axillary dissection?

Jamila Alazhari 🇸🇦

7:10 PM - 7:30 PM

Management guidelines for Phyllodes tumor

Hazem Khout 🇦🇪

7:30 PM - 7:50 PM

Metaplastic breast cancer – What is the optimal evidence based treatment

Huda Alnumani 🇸🇦

7:50 PM - 8:00 PM

7:50 PM - 8:00 PM
Panel Discussion

8:00 PM - 8:15 PM

8:00 PM - 8:15 PM
Prayer & Coffee Break (Exhibition)

12:30 PM - 1:30 PM

Registration

1:30 PM - 2:45 PM

Opening Ceremony

Abstract

4:00 PM - 4:10 PM

MITO12 Mitochondrial Gene Signature Demonstrates Context-Dependent Dual Licensing Mechanism in Metastatic Breast Cancer

Aroub Gomosani

4:10 PM - 4:20 PM

Dual Targeting of Nor-Epinephrine Transport System (NET) and Thyrointegrin αvβ3 Receptors NP855 in the treatment of Neuroendocrine Cancers

Shaker Mousa 🇺🇸

4:20 PM - 4:30 PM

Red Sea Marine Biodiversity as a Precision Oncology Strategy Against Lung Cancer in the Middle East

Mamoon Al-Rshaidat 🇯🇴

4:30 PM - 4:40 PM

Ovarian Cancer: Tumor-Specific Urinary Micro-Peptides Profiling as Potential Biomarkers for Early Diagnosis

Abu Bakr Nasser 🇸🇩

4:40 PM - 4:50 PM

Development of Biodegradable ¹⁶⁶Ho–PCL Rods for Targeted Theranostic Treatment of Liver Cancer

Asseel Alregib 🇲🇾

4:50 PM - 5:00 PM

HDGF as a pivotal regulator of keratinocyte proliferation, migration and differentiation

Heba Eltahir

5:00 PM - 5:10 PM

Treating Acute Leukemia During Pregnancy: Maternal and Fetal Outcomes from a 34-Year Experience

Fatima AlAli 🇸🇦

5:10 PM - 5:20 PM

A Decade of Pediatric-Inspired AYA-15 Protocol in AYA Acute Lymphoblastic Leukemia: Single-Center Outcomes

Ahmed kotb Abdrabou

5:20 PM - 5:30 PM

Bioinformatics Analysis Reveals Epigenetic Regulation of COL5A2 by Tumour-Suppressive miRNAs miR-101-3p and miR-29c-3p as a Potential Molecular Mechanism in Lung Ade-nocarcinoma

Ebtihal Kamal

5:30 PM - 5:40 PM

A Novel Five-Gene Panel Identifies High-Risk Subsets of Invasive Breast Cancer with Prognostic Relevance

Sultan Sonbul 🇸🇦

5:40 PM - 6:00 PM

5:40 PM - 6:00 PM
Panel Discussion
All Panelists

12:30 PM - 1:30 PM

Registration

1:30 PM - 2:45 PM

Opening Ceremony

2:45 PM - 3:30 PM

Keynote

Precision Public Health in Cancer Screening: AI, Social Media, and Targeted Early Detection in the MENA Region

Hadi Rasheed 🇶🇦

3:30 PM - 4:00 PM

3:30 PM - 4:00 PM
Prayer & Coffee Break (Exhibition)

SESSION I

Transforming Oncology Nursing through Value-Based, Person Centered, and Integrated Care

4:00 PM - 4:20 PM

Transforming Oncology Nursing: Magnet Excellence, Person-Centered Care, and Workforce Sustainability

Majeda Alruzzieh 🇯🇴

4:20 PM - 4:40 PM

Value-Based HealthCare: KFSHRC-M Patient Related Outcome Measures (PROMs) using EQ5D-5L & Breast Q-Tools

Raghad Alqash 🇸🇦

Wedyan Alharbi 🇸🇦

4:40 PM - 5:00 PM

Redesigning Care Pathway: IHI Collaboration Learning & Outcome in Palliative & Home Health Care in KFSHRC-M

Samer Seder 🇸🇦

Heba Abdaljwad 🇸🇦

5:00 PM - 5:20 PM

Nursing Role in Integrating Survivorship into Holistic Cancer Care

Sana Khadijah Chaudhry 🇸🇦

Ghada abaalkhail 🇸🇦

5:20 PM - 5:40 PM

Developing a Journey Map for Pediatric Oncology Patients Throughout Their Care Journey in Oncology Units at KFSHRC-M

Febe Valerie Lacson 🇸🇦

Ghofran Baissa 🇸🇦

5:40 PM - 6:00 PM

5:40 PM - 6:00 PM
Panel Discussion

6:00 PM - 6:30 PM

6:00 PM - 6:30 PM
Prayer & Coffee Break (Exhibition)

SESSION II

Transforming Oncology Nursing through Value-Based, Person Centered, and Integrated Care

6:30 PM - 7:05 PM

Unlocking the Economic Power of Care: Eastern Mediterranean Region Priorities for Charting the Nursing leadership & Policy Agenda 2026

Rowaida ALMaaitah 🇯🇴

7:05 PM - 7:15 PM

7:05 PM - 7:15 PM
Panel Discussion

7:15 PM - 7:50 PM

Job Demands and Resources in Palliative Care:Insights from Muslim Nurses in Saudi Arabia

Julie Davies 🇬🇧

7:50 PM - 8:00 PM

7:50 PM - 8:00 PM
Panel Discussion

8:00 PM - 8:15 PM

8:00 PM - 8:15 PM
Prayer & Coffee Break (Exhibition)

Workshop I

Nursing Workshop I

8:15 PM - 8:55 PM

How can AI support healthcare workforce well-being? Ethical insights on job demands and resources from England, India and Saudi Arabia

Julie Davies 🇬🇧

Workshop

Hands on Session – Adjuncts in Oncoplastic Breast Surgery

Station 1

Localization adjuncts

8:15 PM - 8:45 PM

Group 1

8:45 PM - 9:15 PM

Group 4

9:15 PM - 9:45 PM

Group 3

9:45 PM - 10:15 PM

Group 2

Station 2

Meshes and matrices

8:15 PM - 8:45 PM

Group 2

8:45 PM - 9:15 PM

Group 1

9:15 PM - 9:45 PM

Group 4

9:45 PM - 10:15 PM

Group 3

Station 3

Implants and expanders

8:15 PM - 8:45 PM

Group 3

8:45 PM - 9:15 PM

Group 2

9:15 PM - 9:45 PM

Group 1

9:45 PM - 10:15 PM

Group 4

Station 4

Wound management

8:15 PM - 8:45 PM

Group 4

8:45 PM - 9:15 PM

Group 3

9:15 PM - 9:45 PM

Group 2

9:45 PM - 10:15 PM

Group 1

10:15 PM - 10:35 PM

Debriefing and Discussion

Workshop II

Reimagining Workforce: AI Innovations and Nursing Leadership Conversations

Nursing Workshop II

8:55 PM - 9:35 PM

Round Table Session: Nursing Leaders (By invitation Only)

Rowaida ALMaaitah 🇯🇴

Soon

SESSION I

Head & Neck and Endocrine Precision Oncology

8:00 AM - 8:20 AM

HPV-positive and HPV-negative Oropharyngeal SCC Updates

Ammar Sukari 🇺🇸

8:20 AM - 8:40 AM

Updates on Targeted Therapy For Thyroid Cancers

Fahad Wali Ahmed 🇸🇦

8:40 AM - 9:00 AM

New advances in the therapeutic strategy of head and neck squamous cell carcinoma

Ammar Sukari 🇺🇸

9:00 AM - 9:20 AM

Neuroendocrine Tumors: A New Era of Precision Therapy

Mohammed Najeeb Al Hallak 🇺🇸

9:20 AM - 9:30 AM

9:20 AM - 9:30 AM
Panel Discussion

9:30 AM - 9:45 AM

9:30 AM - 9:45 AM
Coffee Break (Exhibition)

SESSION II

Gynecology Oncology & Breast Cancer I

9:45 AM - 10:15 AM

GSK Satellite Symposium

Redefining the Treatment Paradigm in Advanced Ovarian Cancer

Sharif Kullab 🇸🇦

10:15 AM - 10:35 AM

Precision Medicine in Gynecological Cancers

Nashmia Almutairi 🇸🇦

10:35 AM - 10:55 AM

HER2 Spectrum (HER2-positive, HER2-low, HER2-ultra-low) testing update

Maria Hafez 🇺🇸

10:55 AM - 11:15 AM

HER2 Antibody-Drug Conjugates (ADCs) and Combination Strategies

Maria Hafez 🇺🇸

11:15 AM - 11:45 AM

GSK Satellite Symposium:

Immunotherapy in Endometrial Cancer: Evidence, Experience, and Evolving Standards

Nashmia Almutairi 🇸🇦

11:15 AM - 11:30 AM

11:15 AM - 11:30 AM
Panel Discussion

12:00 PM - 2:15 PM

Jumaa Prayer & Lunch

2:15 PM - 3:00 PM

Keynote

Radiotherapy & its impact on the immune system

Mohammad K Khan 🇺🇸

SESSION III

Breast Cancer II

3:00 PM - 3:20 PM

Novartis Satellite Symposium:

Empowering Precision Medicine: Personalized Approaches with CDK 4/6 Inhibitors in Early HR+/HER2- Breast Cancer

Duaa Alkhayat 🇸🇦

3:20 PM - 3:40 PM

Innovations for Hormone Receptor Positive / HER2-Negative Breast Cancer

Hikmat Abdel-Razeq 🇯🇴

3:40 PM - 4:00 PM

Hormone Positive Cancer Therapeutic Sequencing Strategies and ctDNA Integration

Hikmat Abdel-Razeq 🇯🇴

4:00 PM - 4:20 PM

Triple Negative Breast Cancer Therapies Updates

Atlal Abusanad 🇸🇦

4:20 PM - 4:40 PM

AstraZeneca Satellite Symposium:

From Evidence to Impact: Shaping the Future of HER2-Low Treatment

Duaa Alkhayat 🇸🇦

4:40 PM - 4:55 PM

4:40 PM - 4:55 PM
Panel Discussion

4:55 PM - 5:15 PM

4:55 PM - 5:15PM
Asr Prayer &Coffee Break (exhibition)

SESSION IV

GU Malignancies in the Era of Precision Oncology

5:15 PM - 5:35 PM

Amgen Satellite Symposium:

Optimizing ESAs Therapy in Anemia Management

Sharif Kullab 🇸🇦

5:35 PM - 5:55 PM

Prostate Cancer Treatments updates and the furture of Radioactive Therapeutics

Sharif Kullab 🇸🇦

5:55 PM - 6:15 PM

Precision Oncology in Bladder and Urothelial Cancers

Abdullah Al-Sharm 🇸🇦

6:15 PM - 6:35 PM

Triplet Therapy For Renal Cell Carcinomas

Mohamed Aseafan 🇸🇦

6:35 PM - 6:50 PM

6:35 PM - 6:50 PM
Panel Discussion

SESSION I

LEUKEMIA I

8:00 AM - 8:20 AM

Precisive Approach toward Managing Ph+ ALL

Fadi Haddad 🇺🇸

8:20 AM - 8:40 AM

Evolving concepts in MRD and adult B-ALL

Selina Luger 🇺🇸

8:40 AM - 9:00 AM

Untangling the knots in Ph-like ALL

Fadi Haddad 🇺🇸

9:00 AM - 9:20 AM

Amgen Satellite Symposium:


Role of Blinatumomab in the Frontline Consolidation of Ph- ALL

Saleem Eldadh 🇸🇦

9:20 AM - 9:30 AM

9:20 AM - 9:30 AM
Panel Discussion

9:30 AM - 9:45 AM

9:30 AM - 9:45 AM
Coffee Break (Exhibition)

SESSION II

LYMPHOMA I

9:45 AM - 10:05 AM

Kite Pharma Satellite Symposium:

From Bench to Bedside:Yescartas Real -World evidence and the path toward cure in aggressive lymphoma

Olaleken O. Oluwole 🇺🇸

10:05 AM - 10:25 AM

DLBLC molecular subtypes, are we ready for individualized treatments?

Olaleken O. Oluwole 🇺🇸

10:25 AM - 10:45 AM

Updates in T-Cell lymphoma treatment

Dima Alsharkawi 🇬🇧

10:45 AM - 11:05 AM

The role of radiotherapy in lymphoma treatment, does it still have a role in the era of targeted treatments?

Yasser Khafaga 🇸🇦

11:05 AM - 11:25 AM

Bispecific Antibodies, interesting combinations and interesting outcomes

Dima Alsharkawi 🇬🇧

11:25 AM - 11:45 AM

Kite Pharma Satellite Symposium:

Local RWE for the Role of Yescarta in management of R/R DLBCL

Alfadel Alshaibani 🇸🇦

11:45 AM - 12:00 PM

11:45 AM - 12:00 PM 
Panel Discussion

12:00 PM - 2:15 PM

Jumaa Prayer & Lunch

2:00 PM - 2:45 PM

Keynote

Radiotherapy & its impact on the immune system

Mohammad K Khan 🇺🇸

SESSION III

Multiple Myeloma

3:00 PM - 3:20 PM

Johnson & Johnson Satellite Symposium:

Beyond Relapse: Optimizing outcomes with GPRC5D in Relapse Refractory Multiple Myeloma

Enas Motahar 🇸🇦

3:20 PM - 3:40PM

New EHA-EMN 2025 MM guidelines: The use and positioning of new therapeutic drug classes

Ayman Hejazi 🇸🇦

3:40 PM - 4:00 PM

How to manage high risk disease; plasma cell leukemia & extramedullary disease

Ihab Elhemaidi 🇸🇦

4:00 PM - 4:20 PM

Novel approaches to newly diagnosed MM

Saad Usmani 🇺🇸

4:20 PM - 4:40 PM

Defining high-risk disease in MM

Saad Usmani 🇺🇸

4:40 PM - 4:55 PM
Panel Discussion

4:55 PM - 5:15 PM

4:55 PM - 5:15 PM
Asr Prayer &Coffee Break (exhibition)

SESSION IV

LYMPHOMA II

5:15 PM - 5:35 PM

Takeda Satellite Symposium:

From Evidence to Practice: Clinical Insights From the HD21 Study

John Apostolidis 🇸🇦

5:35 PM - 5:55 PM

Follicular lymphoma

Olaleken O. Oluwole 🇺🇸

5:55 PM - 6:15 PM

Sequencing Therapy in CLL

Talha Munir 🇬🇧

6:15 PM - 6:35 PM

Nodular lymphocytes predominate Hodgkin lymphoma

Pamela McKay 🇬🇧

6:35 PM - 6:55 PM

BTK targeting in lymphoma

Talha Munir 🇬🇧

6:55 PM - 7:15 PM

Updates in the management of Hodgkin lymphoma

Pamela McKay 🇬🇧

7:15 PM - 7:30 PM

7:15 AM - 7:30 AM
Panel Discussion

SESSION I

Precision Oncology Therapeutics: The Expanding Role of Clinical Pharmacists

8:00 AM - 8:20 AM

Reimagining Precision Oncology Pharmacotherapy clinic: Lessons from Pharmacogenomics Clinic

Hana Al Alshaykh 🇸🇦

8:20 AM - 8:40 AM

Pharmacist-led oncology clinic for managing chemotheraptic toxicities

Foud Alnajjar 🇸🇦

8:40 AM - 9:00 AM

Bi-specific monoclonal antibodies common toxicities and management

Abeer Alenazi 🇸🇦

9:00 AM - 9:20 AM

9:20 AM - 9:30 AM

9:20 AM - 9:30 AM
Panel Discussion

9:30 AM - 9:45 AM

9:30 AM - 9:45 AM
Coffee Break (Exhibition)

SESSION II

Role of AI in precision oncology

9:45 AM - 10:05 AM

AI in Health Care, General overview

10:05 AM - 10:25 AM

AI in Diagnostic oncology

Abdel Douiri 🇬🇧

10:25 AM - 10:45 AM

AI in Clinical trials

Alan Philips 🇬🇧

10:45 AM - 11:05 AM

Augmented reality navigation and AI in spine surgery

John Shin 🇺🇸

11:05 AM - 11:20 AM

Break & Group Distribution

11:20 AM - 12:20 PM

11:20 AM - 12:20 PM
Panel Discussion

12:00 PM - 2:15 PM

Jumaa Prayer & Lunch

2:00 PM - 2:45 PM

Keynote

Radiotherapy & its impact on the immune system

SESSION III

Cancer genomics and precision oncology

3:00 PM - 3:20 PM

Cell-free Tumor DNA: A revolutionary Tool in Precision Oncology

Mohammad Alshinnag 🇸🇦

3:20 PM - 3:40 PM

Application of Precision Oncology in Myeloid Neoplasms

Mohammad Alshinnag 🇸🇦

3:40 PM - 4:00 PM

Evolving the role of germline oncology in personalized cancer care

Mohammed Algarni 🇸🇦

4:00 PM - 4:20 PM

Clinical application of genetic precision oncology is solid malignancies mainly Breast and GI tumors

Reem Alsulaiman 🇶🇦

4:20 PM - 4:35 PM

Break & Group Distribution

4:55 PM - 5:15PM

4:55 PM - 5:15PM
Asr Prayer &Coffee Break (exhibition)

Soon

SESSION I

Precision in Lung Oncology

8:00 AM - 8:20 AM

How to Overcome Resistance for EGFR-Mutant NSCLC

Mervat Mahrous 🇸🇦

8:20 AM - 9:40 AM

Immunotherapy & Co-mutations for NSCLC

Abdul Rahman Jazieh 🇺🇸

8:40 AM - 9:00 AM

Small Cell Lung Cancer Therapies and Updates

Asrar Alahmadi 🇺🇸

9:00 AM - 9:20 AM

Hikma Satellite Symposium:

Critical role of Comprehensive Genomic Profiling in transforming Precision Oncology

Ibrahim Al Qurashi 🇸🇦

9:20 AM - 9:35 AM

9:20 AM - 9:35 AM
Panel Discussion

9:35 AM - 10:10 AM

9:35 AM - 10:10 AM
Coffee Break (Exhibition)

10:10 AM - 10:50 AM

Keynote

The power of clinical trials and strategic partnerships in successful collaboration development

Taofeek K. Owonikoko 🇺🇸

SESSION II

Sarcoma & Melanoma

11:00 AM - 11:20 AM

Percision in Sarcomas

Marium Hussain 🇺🇸

11:20 AM - 11:40 AM

Melanoma New combination approaches and Overcoming Resistance

Axel Hauschild 🇩🇪

11:40 AM - 11:55 AM

11:40 AM - 11:55 AM
Panel Discussion

SESSION III

Precision in Gastrointestinal Cancers

11:55 AM - 12:15 PM

Amgen Satellite Symposium:


Early Tumor Shrinkage with Panitumumab: Translating Clinical Evidence into Real World Practice

Mervat Mahrous 🇸🇦

12:15 PM - 12:35 PM

Future Directions for Pancreatic Ductal Adenocarcinoma

Asfar Azmi 🇺🇸

12:35 PM - 12:55 PM

Hepatobiliary Combination Therapies Incorporating Immune Check Point Inhibitors Across the Disease Spectrum

Mohammed Salhab 🇸🇦

12:55 PM - 1:15 PM

Challenges and updates for Gastric & Esophageal Cancers Treatments Options

Mohammed Najeeb Al Hallak 🇺🇸

1:15 PM - 1:35 PM

Targeted Colorectal Cancer Therapies

Ali Alfaqih 🇸🇦

1:35 PM - 1:50 PM

1:35 PM - 1:50 PM
Panel Discussion

1:50 PM - 2:50 PM

 Prayer & Lunch 

SESSION IV

Innovative Therapies in Oncology

2:50 PM - 3:10 PM

Kyowa kirin Satellite Symposium:


Role of Mogamulizumab in treat CTCL patients

Alfadel Alshaibani 🇸🇦

3:10 PM - 3:30 PM

Precision Spine Oncology: AI, Augmented Reality, and Advanced Radiology Driving Diagnostic and Outcomes

John Shin 🇺🇸

3:30 PM - 3:50 PM

Therabionic Cancer Therapy: From Bench to FDA Approval

Boris Pasche 🇺🇸

3:50 PM - 4:10 PM

3:50 PM - 4:10 PM
Panel Discussion

SESSION I

LEUKEMIA II

8:00 AM - 8:20 AM

The Role of Targeted Agents in AML Therapy

Selina Luger 🇺🇸

8:20 AM - 8:40 AM

An update on immune checkpoint inhibition in management of higher risk MDS

Amer Zeidan 🇺🇸

8:40 AM - 9:00 AM

MyeloMATCH / Clinical Paradigms in Clinical Trials

Selina Luger 🇺🇸

9:00 AM - 9:20 AM

Telomerase inhibition & TGF pathway targeting in management of lower risk MDS

Amer Zeidan 🇺🇸

9:20 AM - 9:40 AM

Novartis Satellite Symposium:


Asciminib: The Right Balance of Efficacy & Tolerability in CML Treatment

Binyam Usman 🇸🇦

9:40 AM - 9:55 AM

9:40 AM - 9:55 AM
Panel Discussion

9:55 AM - 10:10 AM

9:55 AM - 10:10 AM
Coffee Break (Exhibition)

10:10 AM - 10:50 AM

Keynote

KEY NOTE Lecture: The power of clinical trials and strategic partnerships in successful collaboration development

Taofeek K. Owonikoko 🇺🇸

SESSION II

Stem cell transplant & cellular Therapy I

11:00 AM - 11:20 AM

Choosing the optimal Conditioning Regimen for Patients with AML undergoing Allogeneic Stem Cell Transplantation

Yosra Aljawai 🇺🇸

11:20 AM - 11:40 AM

Stem cell transplant in AML

Rabi Hanna 🇺🇸

11:40 AM - 12:00 PM

Maintenance Therapy for patients with AML after Allogeneic Stem Cell Transplantation

Yosra Aljawai 🇺🇸

12:00 PM - 12:15 PM

12:00 PM - 12:15 PM Panel Discussion

SESSION III

Stem cell transplant & cellular Therapy II

12:15 PM - 12:35 PM

Gene Therapy

Rabi Hanna 🇺🇸

12:35 PM - 12:55 PM

How to establish a cell Therapy program

Ahmad Samer Al-homsi 🇺🇸

12:55 PM - 1:15 PM

Innovations in GVHD prevention

Ahmad Samer Al-homsi 🇺🇸

1:15 PM - 1:35 PM

Post-transplant relapse mitigation

Marcos De Lima 🇺🇸

1:35 PM - 1:50 PM

1:35 PM - 1:50 PM
Panel Discussion

1:50 PM - 2:50 PM

Prayer & Lunch

SESSION IV

Rare Hematologic Disorders & Advanced precison therapy

2:50 PM - 3:10 PM

CAR T-cell therapy: Global access

Marcos De Lima 🇺🇸

3:10 PM - 3:30 PM

How I Treat Advanced Systemic Mastocytosis in 2025

Samah Alimam 🇬🇧

3:30 PM - 3:50 PM

HLH in 2025

Hind Salam 🇸🇦

3:50 PM - 4:10 PM

Hypereosinophilic Syndrome: From Diagnosis to Management

Samah Alimam 🇬🇧

4:10 PM - 4:30 PM

4:10 PM - 4:30 PM
Panel Discussion

SESSION I

Clinical Trials, vision & Future directions I

8:00 AM - 8:25 AM

Organizational structure and leadership for clinical trials

Andrew Grieve 🇬🇧

8:25 AM - 8:50 AM

How to establish a clinical trial cooperative group - learning from the international experience

Ghulam Mufti 🇬🇧

8:50 AM - 9:15 AM

Pragmatic trial design

Abdel Douiri 🇬🇧

9:15 AM - 9:40 AM

9:15 AM - 9:40 AM
Panel Discussion

SESSION II

Clinical Trials, vision & Future directions II

11:00 AM - 11:15 AM

Clinical Trials regulatory Challenges in Saudi Arabia

Riad Alfaqeeh 🇸🇦

11:15 AM - 11:30 AM

Establishing aclinical trial unit in Saudi Arabia, KIMARC experience

Ahmed Alasker 🇸🇦

11:30 AM - 11:45 AM

Establishing Clinical Trial Units (CTU) at the Medical City in King Saud University

Abdullah Aldahmash 🇸🇦

11:45 AM - 12:00 PM

Financing Precision Oncology in Saudi Arabia: How Government and Private Investment Enable Clinical Transformatio

Hamed Alomar 🇸🇦

12:00 PM - 12:15 PM

Clinical Trials: Progress and Challenges, Qatar experience

Chiara Cugno 🇶🇦

12:15 PM - 12:30 PM

International experience

Assem Elbaghdady 🇬🇧

12:30 PM - 12:40 PM

12:30 PM - 12:40 PM
Panel Discussion

12:40 PM - 1:40 PM

How to establish a collaborative group in the middle East

invited guest panel

SESSION III

Liquid Biopsy, cDNA & NGS, new standard of care, how to develop & incorporate in precision oncology

2:50 PM - 3:10 PM

Liquid Biopsy: Hype, Hope, or the New Gold Standard

Khurum Khan 🇬🇧

3:10 PM - 3:30 PM

Use of Liquid biopsy in NSCLC Early Stage: MRD opportunities and challenges

Christian Rolfo 🇺🇸

3:30 PM - 3:50 PM

Liquid Biopsy in NSCLC Advance Disease: Targeted and Immunotherapy focus

Christian Rolfo 🇺🇸

3:50 PM- 4:10 PM

3:50 PM- 4:10 PM Panel Discussion

Contact Us
1

Coming Soon